T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases.
about
Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?Immunotherapy for solid tumors--a review for surgeons.Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based studyThe prognostic value of liver tumor T cell infiltratesp53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responsesPhase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.Induction of endometriosis alters the peripheral and endometrial regulatory T cell population in the non-human primate.Immunotherapy for gastrointestinal malignancies.Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.Diffuse endocrine system, neuroendocrine tumors and immunity: what's new?Surgical treatment and survival in patients with liver metastases from neuroendocrine tumors: a meta-analysis of observational studies.Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.Immunosuppression in liver tumors: opening the portal to effective immunotherapy.Prognostic significance of preoperative gamma-glutamyltransferase to lymphocyte ratio index in nonfunctional pancreatic neuroendocrine tumors after curative resection.PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumours.Immune checkpoint inhibitors in neuroendocrine tumors: A single institution experience with review of literature.
P2860
Q28078610-45208B38-DBCB-497A-8AE7-6039A1DB3B4AQ33709232-FE826EAB-50CA-4163-A6DD-4CB373307E0AQ33743715-FCB1AA99-C0B1-4CF2-92DF-F176005F39D2Q34052611-14FD1C2E-A5CF-48B9-8C98-A2F74B4E5686Q34135426-6088EE59-BCF9-499A-891C-970BC44A80DFQ35862775-F754F0AB-2BBF-4136-A6E7-538BD80F9C78Q35976265-99403F64-DF5D-44E0-BD11-D52A6C3FE3DCQ36602174-FAC0133A-BFD0-4636-B6C8-75D811BF4C0FQ37087293-04B0488F-373E-4980-8285-7112C9999630Q37976162-20DE5644-8F2A-4BAF-9768-6C62F7B69E75Q38091072-6B76040B-05D3-4E74-8674-1062134324ACQ38746782-1D869782-5F23-4F02-95A3-56D786642AA7Q39026963-8E69C8FF-D599-45A6-B8CA-66E85577AB81Q42684243-A89C21A9-8CC7-42FF-9255-126E73519E0CQ52723008-DA1DBB4E-F9A9-4531-A47A-ED740F8A1225Q55376898-F31D3AF4-6670-485B-AE52-4BDCE388B96A
P2860
T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
T cell infiltrate and outcome ...... tumours and liver metastases.
@ast
T cell infiltrate and outcome ...... tumours and liver metastases.
@en
T cell infiltrate and outcome ...... tumours and liver metastases.
@nl
type
label
T cell infiltrate and outcome ...... tumours and liver metastases.
@ast
T cell infiltrate and outcome ...... tumours and liver metastases.
@en
T cell infiltrate and outcome ...... tumours and liver metastases.
@nl
prefLabel
T cell infiltrate and outcome ...... tumours and liver metastases.
@ast
T cell infiltrate and outcome ...... tumours and liver metastases.
@en
T cell infiltrate and outcome ...... tumours and liver metastases.
@nl
P2093
P2860
P1476
T cell infiltrate and outcome ...... tumours and liver metastases.
@en
P2093
Charan Donkor
David S Klimstra
Kristen Glasgow
Laura H Tang
Michael I D'Angelica
Mithat Gönen
N Joseph Espat
Peter J Allen
Ronald P Dematteo
Steven C Katz
P2860
P304
P356
10.1111/J.1477-2574.2010.00231.X
P577
2010-12-01T00:00:00Z